Fluor’s pivot to **reimbursable contracts** (82% of its $28.2B backlog) and its **$605M+ stake in NuScale Power**—a volatile but high-potential nuclear startup—make it a speculative bet. While the engineering giant is stabilizing its cash flow, its cyclical industry and NuScale’s unproven commercial viability mean this stock is only for investors comfortable with **50%+ swings** and a **5+ year horizon**. Here’s how to evaluate the opportunity before the NuScale stake sale completes in mid-2026.
The Reimbursable Contract Revolution: Why It Matters
Fluor’s engineering and construction business has undergone a structural transformation. Historically, the company relied on **fixed-price contracts**, where cost overruns could devastate margins (e.g., its 2018–2020 struggles with a Canadian LNG project that led to a $714M loss). Today, **82% of its $28.2B backlog** is **reimbursable contracts**, where clients cover cost overruns. This shift has:
- Stabilized cash flow: No more surprise write-downs from project delays.
- Improved margins: Gross margins expanded from 2.1% in 2020 to 4.8% in 2025.
- Reduced earnings volatility: Quarterly EPS swings dropped from ±$1.50 to ±$0.30.
Yet, the **cyclical nature of construction** remains. Infrastructure spending surges during economic booms (e.g., 2021–2023’s $1.2T U.S. Infrastructure Bill) but dries up in downturns. Fluor’s revenue dropped **18% in 2020** during the pandemic—proof that even reimbursable contracts can’t fully insulate it from macroeconomic risks.
NuScale Power: The $1B Wild Card
Fluor’s **14% stake in NuScale Power** (NYSE: SMR) is the stock’s most controversial—and potentially lucrative—asset. NuScale’s **small modular reactors (SMRs)** promise safer, cheaper nuclear power, but the company is still pre-revenue. Key realities:
- First commercial project delayed: Romania’s 462MW plant, NuScale’s inaugural sale, won’t break ground until **late 2027** (pushed from 2025).
- Stock collapse: NuScale shares plunged **70% since October 2025**, when Fluor sold part of its stake for $605M. The remaining stake’s value is now uncertain.
- Fluor’s exit strategy: The company plans to sell its entire NuScale position by **mid-2026**, per a pre-arranged deal. Proceeds will fund debt reduction and growth initiatives.
Investor takeaway: NuScale is a **binary bet**. If its Romania project succeeds, Fluor’s stake could be worth **$500M–$1B**. If delays persist or costs balloon, the value may evaporate. This isn’t a “dividend machine”—it’s a **high-risk speculative play** with a 2026 catalyst.
Why the Market Is Underestimating the Risks
Most analysts focus on Fluor’s **backlog growth** (up 12% YoY) and NuScale’s **theoretical upside**, but three red flags demand attention:
- NuScale’s cash burn: The company lost **$213M in 2025** and has just **$350M in cash**. Without Fluor’s support, its runway shortens.
- Regulatory hurdles: The U.S. NRC’s SMR certification process is **18–24 months behind schedule**, per Financial Times.
- Competition: GE Hitachi and Westinghouse are racing to deploy rival SMRs, threatening NuScale’s first-mover advantage.
Who Should Buy Fluor—and Who Should Stay Away
✅ Ideal Investors
- Risk-tolerant traders: Those comfortable with **50%+ drawdowns** and a **3–5 year hold**.
- Nuclear energy bulls: Investors betting on SMRs as the future of clean energy.
- Infrastructure cyclical players: Traders who can time entries around economic cycles (e.g., buying during recessions).
❌ Investors Who Should Avoid
- Dividend seekers: Fluor’s **0.5% yield** is negligible, and payouts may be cut if NuScale’s sale underwhelms.
- Retirees or conservative investors: The stock’s volatility (beta of **1.8**) is unsuitable for low-risk portfolios.
- Short-term traders: The NuScale catalyst won’t resolve until **mid-2026**, and construction cycles take years to play out.
How to Play Fluor in 2026: 3 Scenarios
-
Bull Case ($50+ target): NuScale’s Romania project gets fast-tracked, and Fluor sells its stake for **$800M+**. Construction backlog hits **$30B+** on new infrastructure bills.
- Upside: 60%+ from current levels.
- Probability: 25% (requires regulatory and execution perfection).
-
Base Case ($35 target): NuScale’s stake sells for **$500M**, and Fluor’s core business grows modestly. Stock trades at **12x 2027 earnings**.
- Upside: 20% from current levels.
- Probability: 50% (most likely outcome).
-
Bear Case ($25 target): NuScale’s Romania deal collapses, and Fluor’s stake becomes worthless. A recession cuts construction spending by **15%+**.
- Downside: -30% from current levels.
- Probability: 25% (high if nuclear sentiment sours).
Key Dates to Watch in 2026
- Q1 2026: Fluor’s Q4 2025 earnings (NuScale stake sale updates).
- Mid-2026: Deadline for Fluor to sell remaining NuScale stake.
- Late 2026: Romania’s final investment decision on NuScale’s plant.
- 2027: Potential first revenue from NuScale (if all goes perfectly).
Bottom Line: A Speculative Bet, Not a “Set for Life” Stock
Fluor isn’t a **blue-chip dividend grower** or a **steady compounder**. It’s a **high-risk, high-reward play** on two massive uncertainties:
- Can its **reimbursable contract model** insulate it from the next recession?
- Will **NuScale’s nuclear gamble** pay off before cash runs out?
For investors who can stomach the volatility and are willing to hold until **2027+**, Fluor offers **asymmetric upside**. For everyone else, the risks outweigh the rewards. If you’re hunting for “set for life” stocks, consider the 10 higher-conviction picks from Motley Fool’s Stock Advisor, which have historically crushed the S&P 500 by **4x+**.
Stay ahead of the market: For more razor-sharp analysis on high-risk, high-reward stocks like Fluor, bookmark onlytrustedinfo.com. We cut through the noise to deliver the **fastest, most actionable insights**—so you’re always one step ahead.
